David Dickason
Corporate Officer/Principal presso RESPIRERX PHARMACEUTICALS INC.
Patrimonio netto: - $ in data 30/06/2024
Posizioni attive di David Dickason
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| RESPIRERX PHARMACEUTICALS INC. | Corporate Officer/Principal | 15/09/2020 | - |
Storia della carriera di David Dickason
Precedenti posizioni note di David Dickason
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Iroko Pharmaceuticals LLC
 Iroko Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Iroko Pharmaceuticals LLC develops and distributes pharmaceutical products. It provides approved US products, marketed global, medical information and product patents. The company was founded in 2007 and is headquartered in Philadelphia, PA. | Direttore Tecnico/Scientifico/R&S | 01/01/2010 | 01/01/2016 |
GTx, Inc.
 GTx, Inc. Pharmaceuticals: MajorHealth Technology GTx, Inc. is a a biopharmaceutical company, which engages in the discovery, development, and commercialization of small molecules for the treatment of muscle-related diseases and other serious medical conditions. It focuses on developing selective androgen receptor modulators and selective androgen receptor degrader for the treatment of breast cancer, stress urinary incontinence, Duchenne muscular dystrophy, and prostate cancer. The company was founded by Marc Steven Hanover and Mitchell Shuster Steiner on September 24, 1997 and is headquartered in Memphis, TN. | Corporate Officer/Principal | 01/01/2006 | 01/01/2010 |
Statistiche
Distribuzione geografica
| Stati Uniti | 4 |
Posizioni
| Corporate Officer/Principal | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
Settori
| Health Technology | 4 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| RESPIRERX PHARMACEUTICALS INC. | Health Technology |
| Aziende private | 2 |
|---|---|
GTx, Inc.
GTx, Inc. Pharmaceuticals: MajorHealth Technology GTx, Inc. is a a biopharmaceutical company, which engages in the discovery, development, and commercialization of small molecules for the treatment of muscle-related diseases and other serious medical conditions. It focuses on developing selective androgen receptor modulators and selective androgen receptor degrader for the treatment of breast cancer, stress urinary incontinence, Duchenne muscular dystrophy, and prostate cancer. The company was founded by Marc Steven Hanover and Mitchell Shuster Steiner on September 24, 1997 and is headquartered in Memphis, TN. | Health Technology |
Iroko Pharmaceuticals LLC
Iroko Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Iroko Pharmaceuticals LLC develops and distributes pharmaceutical products. It provides approved US products, marketed global, medical information and product patents. The company was founded in 2007 and is headquartered in Philadelphia, PA. | Health Technology |
- Borsa valori
- Insiders
- David Dickason
- Esperienza
